NCT00387868View on ClinicalTrials.gov

Preoperative Treatment of Patients With High Risk Thymoma

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2014

Conditions
Thymoma
Interventions
DRUG

cisplatin and etoposide

Cisplatin: 50mg/m2 - administered on days 1,8,29\&36 Etoposide: 50 mg/m2 - administered on days 1-5 \& 29-33

PROCEDURE

Surgical Resection

Resection will take place 4-8 weeks after completion of radiotherapy.

RADIATION

Concurrent Radiotherapy

Preoperative External Beam Radiotherapy

Trial Locations (2)

07450

Valley Health System - The Valley Hospital, Ridgewood

M5G2C4

University of Toronto, Toronto

All Listed Sponsors
lead

Valley Health System

OTHER

NCT00387868 - Preoperative Treatment of Patients With High Risk Thymoma | Biotech Hunter | Biotech Hunter